These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11203054)

  • 21. Pharmaceuticals: a closer look.
    Peters B
    Mich Health Hosp; 2000; 36(1):12-4. PubMed ID: 11184282
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of new drug introduction on drug expenditure in primary health care in Catalunya, Spain.
    Zara C; Torralba M; Sotoca JM; Prat A; Faixedas MT; Gilabert A
    Ann Pharmacother; 2005 Jan; 39(1):177-82. PubMed ID: 15572601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Explaining the demand for pharmaceuticals in Spain: are there differences in drug consumption between foreigners and the Spanish population?
    Jiménez-Rubio D; Hernández-Quevedo C
    Health Policy; 2010 Oct; 97(2-3):217-24. PubMed ID: 20807684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription drugs in nursing homes: managing costs and quality in a complex environment.
    Mendelson D; Ramchand R; Abramson R; Tumlinson A
    NHPF Issue Brief; 2002 Nov; (784):1-18. PubMed ID: 12463231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic aspects of drug use.
    Haaijer-Ruskamp FM; Dukes MN
    WHO Reg Publ Eur Ser; 1993; 45():125-45. PubMed ID: 8442842
    [No Abstract]   [Full Text] [Related]  

  • 28. Increasing use of new prescription drugs: a case study.
    Foote SM; Etheredge L
    Health Aff (Millwood); 2000; 19(4):165-70. PubMed ID: 10916970
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceutical starter samples.
    Teichman PG; Caffee AE
    J Am Board Fam Pract; 2002; 15(6):509-10. PubMed ID: 12463302
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription drug trend begins showing modest slowdown.
    Capitation Rates Data; 2002 Jul; 7(7):76-80. PubMed ID: 12164063
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-sharing for prescription drugs.
    Gibson TB; McLaughlin CG; Smith DG
    JAMA; 2001 May; 285(18):2328-9. PubMed ID: 11343477
    [No Abstract]   [Full Text] [Related]  

  • 32. [Don't restrict the free right of prescription!].
    Bågenholm EN
    Lakartidningen; 2002 Mar; 99(10):1093-4. PubMed ID: 12024787
    [No Abstract]   [Full Text] [Related]  

  • 33. New drugs for dementia: a commissioning nightmare?
    Johnson R
    Int J Geriatr Psychiatry; 1999 Apr; 14(4):257-8. PubMed ID: 10340184
    [No Abstract]   [Full Text] [Related]  

  • 34. [Development of use of subsidized prescription drugs. A comparison of drug consumption requiring subsidy in the county of Storstrøm during the periods 1 January--30 April 1991 and 1 January--30 April 1992].
    Jensen PB; Vass M
    Ugeskr Laeger; 1993 Jun; 155(26):2020-4. PubMed ID: 8328040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary care groups and the right to prescribe.
    Newdick C
    BMJ; 1998 Nov; 317(7169):1361-4. PubMed ID: 9812936
    [No Abstract]   [Full Text] [Related]  

  • 36. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex, and temporary resident originated prescribing unit).
    Whynes DK; Baines DL; Tolley KH
    BMJ; 1996 Feb; 312(7029):488-9. PubMed ID: 8597684
    [No Abstract]   [Full Text] [Related]  

  • 38. Who bears the burden of Medicaid drug copayment policies?
    Stuart B; Zacker C
    Health Aff (Millwood); 1999; 18(2):201-12. PubMed ID: 10091449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rx cost control: what's your role?
    Guglielmo WJ
    Med Econ; 2003 Feb; 80(4):27-8, 31-2. PubMed ID: 12666646
    [No Abstract]   [Full Text] [Related]  

  • 40. [Quality reports reduce drug costs in primary health care. Stockholm County Council a model for decentralized expenditure responsibility].
    Almkvist H; Bergman U; Edlert M; Juhasz-Haverinen M; Pehrsson A; Bergen-Dahl GT; Veg A; Wettermark B
    Lakartidningen; 2008 Oct 15-21; 105(42):2930-4. PubMed ID: 19025150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.